Evercore ISI Group Maintains Outperform on Repligen, Raises Price Target to $160

Benzinga Newsdesk www.benzinga.com Positive 90.2%

Neg 0% Neu 0% Pos 90.2%

Evercore ISI Group analyst Daniel Markowitz maintains Repligen (NASDAQ:RGEN) with a Outperform and raises the price target from $150 to $160.